In their study, pretreatment with anti-RET agents such as 1-methoxy PMS (MPMS) or dimethyl fumarate (DMF) not only alleviated hemophagocytic lymphohistiocytosis (HLH) pathology but also significantly reduced PANoptotic features in the liver and kidneys [186]. This evidence concerns the gene RET and hemophagocytic syndrome.